201 related articles for article (PubMed ID: 12375161)
21. Toxoplasma gondii: inhibitory activity and encystation effect of securinine and pyrrolidine derivatives on Toxoplasma growth.
Holmes M; Crater AK; Dhudshia B; Thadani AN; Ananvoranich S
Exp Parasitol; 2011 Feb; 127(2):370-5. PubMed ID: 20833168
[TBL] [Abstract][Full Text] [Related]
22. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
[TBL] [Abstract][Full Text] [Related]
23. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative synergism of azasterols and antifolates against Toxoplasma gondii.
Dantas-Leite L; Urbina JA; de Souza W; Vommaro RC
Int J Antimicrob Agents; 2005 Feb; 25(2):130-5. PubMed ID: 15664482
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anti-toxoplasmosis activity of 4-arylquinoline-2-carboxylate derivatives.
McNulty J; Vemula R; Bordón C; Yolken R; Jones-Brando L
Org Biomol Chem; 2014 Jan; 12(2):255-60. PubMed ID: 24276426
[TBL] [Abstract][Full Text] [Related]
26. 1,4-Disubstituted thiosemicarbazide derivatives are potent inhibitors of Toxoplasma gondii proliferation.
Dzitko K; Paneth A; Plech T; Pawełczyk J; Stączek P; Stefańska J; Paneth P
Molecules; 2014 Jul; 19(7):9926-43. PubMed ID: 25010466
[TBL] [Abstract][Full Text] [Related]
27. Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro.
da Silva LL; Portes Jde A; de Araújo MH; Silva JL; Rennó MN; Netto CD; da Silva AJ; Costa PR; De Souza W; Seabra SH; DaMatta RA
Parasitol Int; 2015 Dec; 64(6):622-31. PubMed ID: 26335616
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
Alves CF; Vitor RW
Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
[TBL] [Abstract][Full Text] [Related]
29. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
30. Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
De Pablos LM; González G; Rodrigues R; García Granados A; Parra A; Osuna A
J Nat Prod; 2010 May; 73(5):831-4. PubMed ID: 20441162
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiprotozoal activity of naphthofuranquinones and naphthothiophenequinones containing a fused thiazole ring.
Tapia RA; Alegria L; Pessoa CD; Salas C; Cortés MJ; Valderrama JA; Sarciron ME; Pautet F; Walchshofer N; Fillion H
Bioorg Med Chem; 2003 May; 11(10):2175-82. PubMed ID: 12713827
[TBL] [Abstract][Full Text] [Related]
32. One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii.
Brown CE; Kong T; Bordón C; Yolken R; Jones-Brando L; McNulty J
Bioorg Med Chem Lett; 2018 May; 28(9):1642-1646. PubMed ID: 29598911
[TBL] [Abstract][Full Text] [Related]
33. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
[TBL] [Abstract][Full Text] [Related]
34. Antiprotozoal and cytotoxic screening of 45 plant extracts from Democratic Republic of Congo.
Mesia GK; Tona GL; Nanga TH; Cimanga RK; Apers S; Cos P; Maes L; Pieters L; Vlietinck AJ
J Ethnopharmacol; 2008 Feb; 115(3):409-15. PubMed ID: 18068320
[TBL] [Abstract][Full Text] [Related]
35. Mutants of Toxoplasma gondii resistant to atovaquone (566C80) or decoquinate.
Pfefferkorn ER; Borotz SE; Nothnagel RF
J Parasitol; 1993 Aug; 79(4):559-64. PubMed ID: 8331476
[TBL] [Abstract][Full Text] [Related]
36. Selective anti-Toxoplasma gondii activities of azasterols.
Dantas-Leite L; Urbina JA; de Souza W; Vommaro RC
Int J Antimicrob Agents; 2004 Jun; 23(6):620-6. PubMed ID: 15194134
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, anti-Toxoplasma gondii and antimicrobial activities of benzaldehyde 4-phenyl-3-thiosemicarbazones and 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5-thiazolidineacetic acids.
de Aquino TM; Liesen AP; da Silva RE; Lima VT; Carvalho CS; de Faria AR; de Araújo JM; de Lima JG; Alves AJ; de Melo EJ; Góes AJ
Bioorg Med Chem; 2008 Jan; 16(1):446-56. PubMed ID: 17905587
[TBL] [Abstract][Full Text] [Related]
38. Anti-Toxoplasma gondii RH strain activity of herbal extracts used in traditional medicine.
Choi KM; Gang J; Yun J
Int J Antimicrob Agents; 2008 Oct; 32(4):360-2. PubMed ID: 18619816
[TBL] [Abstract][Full Text] [Related]
39. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
Gangjee A; Adair OO; Queener SF
J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
